213 related articles for article (PubMed ID: 26473322)
1. Design and Development of Immunomodulatory Antigen Delivery Systems Based on Peptide/PEG-PLA Conjugate for Tuning Immunity.
Coumes F; Huang CY; Huang CH; Coudane J; Domurado D; Li S; Darcos V; Huang MH
Biomacromolecules; 2015 Nov; 16(11):3666-73. PubMed ID: 26473322
[TBL] [Abstract][Full Text] [Related]
2. Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide.
Chen WL; Liu SJ; Leng CH; Chen HW; Chong P; Huang MH
Biomaterials; 2014 Feb; 35(5):1686-95. PubMed ID: 24268203
[TBL] [Abstract][Full Text] [Related]
3. Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy.
Huang CH; Huang CY; Cheng CP; Dai SH; Chen HW; Leng CH; Chong P; Liu SJ; Huang MH
Sci Rep; 2016 Nov; 6():36732. PubMed ID: 27827451
[TBL] [Abstract][Full Text] [Related]
4. A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity.
Song YC; Cheng HY; Leng CH; Chiang SK; Lin CW; Chong P; Huang MH; Liu SJ
J Control Release; 2014 Jan; 173():158-65. PubMed ID: 24177312
[TBL] [Abstract][Full Text] [Related]
5. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
[TBL] [Abstract][Full Text] [Related]
6. Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus.
Huang MH; Dai SH; Chong P
Microbes Infect; 2016 Nov; 18(11):706-709. PubMed ID: 27394146
[TBL] [Abstract][Full Text] [Related]
7. Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity.
Huang CH; Huang CY; Huang MH
Mol Pharm; 2018 Feb; 15(2):420-429. PubMed ID: 29237267
[TBL] [Abstract][Full Text] [Related]
8. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.
Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X
Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834
[TBL] [Abstract][Full Text] [Related]
9. Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy.
Masuko K; Wakita D; Togashi Y; Kita T; Kitamura H; Nishimura T
Immunol Lett; 2015 Jan; 163(1):102-12. PubMed ID: 25479286
[TBL] [Abstract][Full Text] [Related]
10. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
11. Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy.
Luo L; Liu C; He T; Zeng L; Xing J; Xia Y; Pan Y; Gong C; Wu A
Nanoscale; 2018 Nov; 10(46):22035-22043. PubMed ID: 30452049
[TBL] [Abstract][Full Text] [Related]
12. Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment.
Zhao H; Zhao B; Wu L; Xiao H; Ding K; Zheng C; Song Q; Sun L; Wang L; Zhang Z
ACS Nano; 2019 Nov; 13(11):12553-12566. PubMed ID: 31689085
[TBL] [Abstract][Full Text] [Related]
13. Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.
Ahmed KK; Geary SM; Salem AK
J Pharm Sci; 2016 Mar; 105(3):1173-9. PubMed ID: 26886334
[TBL] [Abstract][Full Text] [Related]
14. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes.
Jeanbart L; Ballester M; de Titta A; Corthésy P; Romero P; Hubbell JA; Swartz MA
Cancer Immunol Res; 2014 May; 2(5):436-47. PubMed ID: 24795356
[TBL] [Abstract][Full Text] [Related]
15. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
Stano A; Scott EA; Dane KY; Swartz MA; Hubbell JA
Biomaterials; 2013 Jun; 34(17):4339-46. PubMed ID: 23478034
[TBL] [Abstract][Full Text] [Related]
16. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
[TBL] [Abstract][Full Text] [Related]
17. The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.
Kovacs-Nolan J; Latimer L; Landi A; Jenssen H; Hancock RE; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2009 Mar; 27(14):2055-64. PubMed ID: 19428830
[TBL] [Abstract][Full Text] [Related]
18. PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy.
Ochyl LJ; Bazzill JD; Park C; Xu Y; Kuai R; Moon JJ
Biomaterials; 2018 Nov; 182():157-166. PubMed ID: 30121425
[TBL] [Abstract][Full Text] [Related]
19. Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy.
Luo Z; Li P; Deng J; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
J Control Release; 2013 Sep; 170(2):259-67. PubMed ID: 23742880
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis.
Toyoda M; Hama S; Ikeda Y; Nagasaki Y; Kogure K
Int J Pharm; 2015 Apr; 483(1-2):110-4. PubMed ID: 25681719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
